Synthesis and Anti‐Hepatitis B Virus Evaluation of 7‐Methoxy‐3‐heterocyclic quinolin‐6‐ols

By  

ARCHIV DER PHARMAZIE (ELECTRONIC), Vol. 348, Iss. 11, 2015-11 ,pp. : 776-785

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of patients with hepatitis C virus genotype 3: Where are we now?

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 4, 2015-10 ,pp. : 79-81

John Wiley & Sons Inc

Access to resources Recommend Favorite

The new treatments for hepatitis C virus: An advanced practice provider's perspective

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 4, Iss. 6, 2014-12 ,pp. : 153-155

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of the Resistance of Hepatitis C Virus NS5B Polymerase Inhibitors via Docking and Molecular Dynamics Simulation

By  

MOLECULAR INFORMATICS, Vol. 34, Iss. 2‐3, 2015-02 ,pp. : 78-83

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synthesis of deleobuvir, a potent hepatitis C virus polymerase inhibitor, and its major metabolites labeled with carbon‐13 and carbon‐14

By  

JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS (ELECTRONIC), Vol. 58, Iss. 6, 2015-05 ,pp. : 250-260

John Wiley & Sons Inc

Access to resources Recommend Favorite